{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T00:26:05Z","timestamp":1772497565856,"version":"3.50.1"},"reference-count":20,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":6056,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["British Journal of Dermatology"],"published-print":{"date-parts":[[1999,2]]},"DOI":"10.1046\/j.1365-2133.1999.02672.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T05:14:35Z","timestamp":1047359675000},"page":"338-342","source":"Crossref","is-referenced-by-count":131,"title":["Erosive mucosal lichen planus: response to topical treatment with tacrolimus"],"prefix":"10.1093","volume":"140","author":[{"family":"VENTE","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"REICH","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"RUPPRECHT","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"NEUMANN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","reference":[{"key":"10.1046\/j.1365-2133.1999.02672.x-BIB1","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1111\/1523-1747.ep12456939","article-title":"Immunosuppressive macrolides of the type FK 506: a novel class of topical agents for treatment of skin diseases?","volume":"98","author":"Meingassner","year":"1992","journal-title":"J Invest Dermatol"},{"key":"10.1046\/j.1365-2133.1999.02672.x-BIB2","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1001\/archderm.1996.03890280081011","article-title":"The European FK 506 Multicentre Psoriasis Study Group. Systemic tacrolimus (FK 506) is effective for the treatment of psoriasis in a double-blind, placebo controlled study.","volume":"132","year":"1996","unstructured":"2 The European FK 506 Multicentre Psoriasis Study Group. Systemic tacrolimus (FK 506) is effective for the treatment of psoriasis in a double-blind, placebo controlled study. Arch Dermatol 1996; 132: 419 23.","journal-title":"Arch Dermatol"},{"key":"10.1046\/j.1365-2133.1999.02672.x-BIB3","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1001\/archderm.1992.01680160065005","article-title":"Tacrolimus (FK 506)\ufffd\ufffd\ufffda new therapeutic agent for severe recalcitrant psoriasis.","volume":"128","author":"Jegasothy","year":"1992","journal-title":"Arch Dermatol"},{"key":"10.1046\/j.1365-2133.1999.02672.x-BIB4","first-page":"3328","article-title":"Efficacy of FK 506 in the treatment of recalcitrant pyoderma gangrenosum.","volume":"123","author":"Abu-Elmagd","year":"1991","journal-title":"Transplant Proc"},{"key":"10.1046\/j.1365-2133.1999.02672.x-BIB5","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/j.1365-2133.1995.tb02691.x","article-title":"Successful treatment of resistant facial lesions of atopic dermatitis with 0.1% FK 506 ointment.","volume":"133","author":"Aoyama","year":"1995","journal-title":"Br J Dermatol"},{"key":"10.1046\/j.1365-2133.1999.02672.x-BIB6","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1159\/000247133","article-title":"Topical FK 506\ufffd\ufffd\ufffdclinical potential or laboratory curiosity?","volume":"188","author":"Lauerma","year":"1994","journal-title":"Dermatology"},{"key":"10.1046\/j.1365-2133.1999.02672.x-BIB7","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1056\/NEJM199709183371203","article-title":"The European Tacrolimus Multicenter Atopic Dermatitis Study Group. A short-term trial of tacrolimus ointment for atopic dermatitis.","volume":"337","author":"Ruzicka","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1046\/j.1365-2133.1999.02672.x-BIB8","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1046\/j.1365-2133.1998.02164.x","article-title":"Vulval lichen planus.","volume":"138","author":"Lewis","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1046\/j.1365-2133.1999.02672.x-BIB9","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/0190-9622(91)70241-S","article-title":"Lichen planus.","volume":"25","author":"Boyd","year":"1991","journal-title":"J Am Acad Dermatol"},{"key":"10.1046\/j.1365-2133.1999.02672.x-BIB10","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1600-0714.1988.tb01527.x","article-title":"Course of various clinical forms of oral lichen planus: a prospective follow up of 611 patients.","volume":"17","author":"Thorn","year":"1988","journal-title":"J Oral Pathol Med"},{"key":"10.1046\/j.1365-2133.1999.02672.x-BIB11","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0190-9622(88)70011-0","article-title":"Immunopathological study of lichenoid skin diseases: correlation between HLA-DR positive keratinocytes of Langerhans-cells and epidermotropic T cells.","volume":"18","author":"Shiohara","year":"1988","journal-title":"J Am Acad Dermatol"},{"key":"10.1046\/j.1365-2133.1999.02672.x-BIB12","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/1523-1747.ep12606990","article-title":"Characteristic cytokines generated by keratinocytes and mononuclear infiltrates in oral lichen planus.","volume":"104","author":"Yamamoto","year":"1995","journal-title":"J Invest Dermatol"},{"key":"10.1046\/j.1365-2133.1999.02672.x-BIB13","first-page":"55","article-title":"Lichen planus, chronic liver diseases and immunologic involvement.","volume":"280","author":"Cottini","year":"1988","journal-title":"Arch Dermatol Res"},{"issue":"(Suppl.)","key":"10.1046\/j.1365-2133.1999.02672.x-BIB14","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/jid.1995.15","article-title":"In three types of interface dermatitis, different patterns of expression of intercellular adhesion molecule-1 (ICAM-1) indicate different triggers of disease.","volume":"105","author":"Bennion","year":"1995","journal-title":"J Invest Dermatol"},{"key":"10.1046\/j.1365-2133.1999.02672.x-BIB15","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1136\/bmj.300.6719.227","article-title":"Lichen planus and liver disease: a multicenter case\ufffd\ufffd\ufffdcontrol study.","volume":"300","author":"Gruppo Italiano Studi Epidemiologici in Dermatologia (GISED)","year":"1990","journal-title":"Br Med J"},{"key":"10.1046\/j.1365-2133.1999.02672.x-BIB16","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1111\/j.1365-2133.1996.tb06977.x","article-title":"Lichen planus and hepatitis C virus: prevalence and clinical presentation of patients with lichen planus and hepatitis C virus infection.","volume":"134","author":"Sanchez-Perez","year":"1996","journal-title":"Br J Dermatol"},{"key":"10.1046\/j.1365-2133.1999.02672.x-BIB17","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1046\/j.1365-2362.1996.610607.x","article-title":"Development and exacerbation of oral lichen planus during and after interferon therapy for hepatitis C.","volume":"26","author":"Nagao","year":"1996","journal-title":"Eur J Clin Invest"},{"key":"10.1046\/j.1365-2133.1999.02672.x-BIB18","first-page":"507","article-title":"Lichen planus associated with liver disease caused by hepatitis C virus.","volume":"19","author":"Jauregui","year":"1996","journal-title":"Gastroenterol Hepatol"},{"key":"10.1046\/j.1365-2133.1999.02672.x-BIB19","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/0140-6736(90)90766-X","article-title":"Cyclosporin wash for oral lichen planus.","volume":"335","author":"Eisen","year":"1990","journal-title":"Lancet"},{"key":"10.1046\/j.1365-2133.1999.02672.x-BIB20","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1111\/j.1365-2133.1995.tb00728.x","article-title":"Topical cyclosporin in oral lichen planus: a controlled, randomized prospective trial.","volume":"132","author":"Sieg","year":"1995","journal-title":"Br J Dermatol"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2133.1999.02672.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1046\/j.1365-2133.1999.02672.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T12:23:44Z","timestamp":1676377424000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/140\/2\/338\/6683960"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,2]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1999,2]]}},"URL":"https:\/\/doi.org\/10.1046\/j.1365-2133.1999.02672.x","relation":{},"ISSN":["0007-0963","1365-2133"],"issn-type":[{"value":"0007-0963","type":"print"},{"value":"1365-2133","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,2]]}}}